AXSM — Axsome Therapeutics, Inc. stock price, charts and financials

QT60Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
212.17
+1.13+0.54%
OverviewShort InterestFilings
AXSMQT60Axsome Therapeutics, Inc.·NASDAQ
212.17+0.54%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 15, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 09, 20268-KCurrent report
Jun 03, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 04, 20268-KCurrent report
May 04, 202610-QQuarterly report
Apr 30, 20268-KCurrent report
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Apr 24, 2026ARSAnnual report to shareholders
#1 / 25 of 280
Page
▼
/ 12